1. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K, Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 2000;44: 2276-2285.　
2. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K, Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001;357: 1225-1240.
3. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K, Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359: 1819-1827.
4. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K, Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 2003;41: 5-1
5. Hiramatsu K, Cui L, Kuwahara-Arai K, Has vancomycin-resistant Staphylococcus aureus started going it alone? Lancet 2004;364: 565-566.
6. Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K, DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2005;49: 3404-3413.
7. Cui L, Tominaga E, Neoh HM, Hiramatsu K, Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006;50: 1079-1082.
8. Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K, Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006;50: 428-438.
   
9. Cui L, Neoh HM, Shoji M, Hiramatsu K, Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2009;53: 1231-1234.
10. Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K, An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob Agents Chemother 2010;54: 5222-5233.
11. Cui L, Neoh HM, Iwamoto A, Hiramatsu K, Coordinated phenotype switching with large-scale chromosome flip-flop inversion observed in bacteria. Proc Natl Acad Sci U S A 2012;109: E1647-1656.
12. Watanabe S, Cui B, Kiga K, Aiba Y, Tan X, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam AH, Nakada Y, Sasahara T, Cui L.  Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia.　Front. Microbiol. 2019  doi:10.3389/fmicb.
    
13. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Sato’o Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.　Nat Commun 11, 2934 (2020).
    

1. Watanabe S, Ito T, Takeuchi F, Endo M, Okuno E, Hiramatsu K. Structural comparison of ten serotypes of staphylocoagulases in Staphylococcus aureus. J Bacteriol. 2005 Jun;187(11):3698-707.
2. Watanabe S, Ito T, Morimoto Y, Takeuchi F, Hiramatsu K. Precise excision and self-integration of a composite transposon as a model for spontaneous large-scale chromosome inversion/deletion of the Staphylococcus haemolyticus clinical strain JCSC1435. J Bacteriol 2007; 189(7):2921-5.
3. Watanabe S, Ito T, Hiramatsu K. Susceptibilities of healthcare- and community-associated methicillin-resistant staphylococci to the novel des-F(6)-quinolone DX-619. J Antimicrob Chemother 2007; 60(6):1384-7.
4. Watanabe S, Ito T, Sasaki T, Li S, Uchiyama I, Kishii K, Kikuchi K, Skov RL, Hiramatsu K. Genetic diversity of staphylocoagulase genes (coa): insight into the evolution of variable chromosomal virulence factors in Staphylococcus aureus. PLoS One 2009; 4(5):e5714.
5. Watanabe S, Goodwin M, Barry CE 3rd, Boshoff HI. Fumarate Reductase Activity Maintains an Energized Membrane in Anaerobic Mycobacterium tuberculosis. PLoS Pathog 2011; 7(10):e1002287.
6. Watanabe S, Shimomura Y, Ubukata K, Kirikae T, Miyoshi-Akiyama T. Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group G streptococci. J Infect Dis 2013; 208(9):1482-93.
7. Watanabe S, Kirikae T, Miyoshi-Akiyama T. Complete genome sequence of Streptococcus dysgalactiae subsp. equisimilis 167 carrying Lancefield group C antigen and comparative genomics of S. dysgalactiae subsp. equisimilis strains. Genome Biol Evol 2013; 5(9):1644-51.
8. Watanabe S, Takemoto N, Ogura K, Miyoshi-Akiyama T. Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis. Microbiol Immunol. 2016 60(1):1-9.
9. Watanabe S, Matsumura K, Iwai H, Funatogawa K, Haishima Y, Fukui C, Okumura K, Kato-Miyazawa M, Hashimoto M, Teramoto K, Kirikae F, Miyoshi-Akiyama T, Kirikae T. A Mutation in the 16S rRNA Decoding Region Attenuates the Virulence of Mycobacterium tuberculosis. Infect Immun. 2016. 84(8):2264-73.
10. Watanabe S, Sasahara T, Arai N, Sasaki K, Aiba Y, Sato'o Y, Cui L. Complete Genome Sequence of Streptococcus pyogenes Strain JMUB1235 Isolated from an Acute Phlegmonous Gastritis Patient. Genome Announc. 2016. 4(5).
11. Watanabe S, Cui B, Kiga K, Aiba Y, Tan X, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam AH, Nakada Y, Sasahara T, Cui L.  Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia.　Front. Microbiol. 2019  doi:10.3389/fmicb.

1. Tanji Y, Murofushi K, Miyanaga K. Quick selection of a chimeric T2 phage that displays active enzyme on the viral capsid. Biotechnol Prog. 2005; 21:1768-1771.
2. Miyanaga K, Hijikata T, Furukawa C, Unno H, Tanji Y. Detection of Escherichia coli in the sewage influent by fluorescent labeled T4 phage. Biochem Eng J. 2006; 29:119-124.
3. Miyanaga K, Takano S, Morono Y, Hori K, Unno H, Tanji Y. Optimization of distinction between viable and dead cells by fluorescent staining method and its application to bacterial consortia. Biochem Eng J. 2007; 37(1):56-61.
4.  Miyanaga K,Terashi R,Kawai K,Unno H,Tanji Y. Effects of pH increase derived from cathodic protection on bacterial viability in proximity to carbon steel. Biotechnol Bioeng. 2007; 97(4): 850-857.
5. Hu J, Miyanaga K, Tanji Y. Diffusion of bacteriophages through artificial biofilm models. Biotechnol Prog. 2012; 28(2):319-326.
6. Tanji Y, Tanaka A, Tani K, Kurimoto M, Miyanaga K. IgG-dependent aggregation of Staphylococcus aureus inhibits bacteriophage attack. Biochem Eng J. 2015; 97:17-24.
7. Azam AH, Hoshiga F, Takeuchi I, Miyanaga K, Tanji Y. Analysis of phage resistance in Staphylococcus aureus SA003 reveals different binding mechanism for the closely related Twort-like phages ΦSA012 and ΦSA039. Appl Microbiol Biotechnol. 2018; 102(20):8963-8977.
8. Ung P, Peng C, Yuk S, Tan R, Ann V, Miyanaga K, Tanji Y. Dynamics of bacterial community in Tonle Sap Lake, a large tropical flood-pulse system in southeast Asia. Sci Total Environ.2019; 664,:414-423.
9. Peng C,Hanawa T,Azam AH,LeBlanc C,Ung P,Matsuda T,Onishi H, Miyanaga K, Tanji Y. Silviavirus phage ΦMR003 displays a broad host range against methicillin-resistant Staphylococcus aureus of human origin. Appl Microbiol Biotechnol. 2019; 103(18):7751-7765.
10. Nishio J, Negishi H, Yasui-Kato M, Miki S, Miyanaga K, Aoki K, Mizusawa T, Ueno M, Ainai A, Muratani M, Hangai S, Yanai H, Hasegawa H, Ishii Y, Tanji Y, Taniguchi Y. Identification and characterization of a novel Enterococcus bacteriophage with potential to ameliorate murine colitis. Sci Rep. 2021; 11(1):1-13.

1. Fukao T, Fukuda Y, Kiga K, Sharif J, Hino K, Enomoto Y, Kawamura A, Nakamura K, Takeuchi T, Tanabe M. An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. Cell 2007;129(3): p617-631.
2. Suzuki M, Mimuro H, Kiga K, Fukumatsu M, Ishijima N, Morikawa H, Nagai S, Koyasu S, Gilman R, Kersulyte D, Berg D, Sasakawa C. Helicobacter pylori CagA Phosphorylation-Independent Function in Epithelial Proliferation and Inflammation. Cell Host Microbe 2009;5(1): p23-34.
3. Suzuki M, Kiga K, Kersulyte D, Cok J, Hooper C, Mimuro H, Sanada T, Suzuki S, Oyama M, Kozuka-Hata H, Kamiyae S, Zou Q, Gilman R, Berg D, Sasakawa C. Attenuated CagA Oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon. J Biol Chem 2011;286(34): p29964-29972.
4. Iwasaki Y*, Kiga K*, Kayo H, Fukuda-Yuzawa Y, Weise J, Inada T, Tomita M, Ishihama Y, Fukao T. Global microRNA elevation by inducible Exportin 5 regulates cell cycle entry. RNA 2013;19(4): p490-497.
5. Kayo H*, Kiga K*, Fukuda-Yuzawa Y*, Hedlund S, Murakami K, Rosa-Velazquez I, Kimura T, Shimoda K, Tanabe M, Fukao T. miR-212 and miR-132 are dispensable for mouse mammary gland development. Nature Genet 2014;46(8): p802-804.
6. Kiga K*, Mimuro H*, Suzuki M, Shinozaki-Ushiku A, Kobayashi T, Sanada T, Kim M, Ogawa M, Iwasaki Y, Kayo H, Fukuda-Yuzawa Y, Yashiro M, Fukayama M, Fukao T, Sasakawa C. Epigenetic silencing of miR-210 increases the proliferation of gastric epithelium during chronic Helicobacter pylori infection. Nat Commun 2014; 5:4497.
7. Kiga K#, Fukuda-Yuzawa Y, Tanabe M, Tsuji S, Sasakawa C, Fukao T#. Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer. RNA Biol 2014;11(11): p1347-1354.
8. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Sato’o Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria.　Nat Commun 11, 2934 (2020) .
9. 
   

1. Sasahara T, Hayashi S, Hosoda K, Morisawa Y, and Hirai Y. Comparison of Hand Hygiene Procedures for Removing Bacillus cereus Spores. Biocontrol Sci 2014;19:129-134.
2. Sasahara T, Hayashi S, Morisawa Y, Sakihama T, Yoshimura A, Hirai Y. Bacillus cereus bacteremia outbreak due to contaminated hospital linens. Eur J Clin Microbiol Infect Dis 2011;30:219-26.
3. Oda M, Hashimoto M, Takahashi M, Ohmae Y, Seike S, Kato R, Fujita A, Tsuge H, Nagahama M, Ochi S, Sasahara T, Hayashi S, Hirai Y, Sakurai J. Role of sphingomyelinase in infectious diseases caused by Bacillus cereus. PLoS One 2012;7:e38054.
4. Ogawa M and Sasahara T. A pilot study on the stability of toluene in blood from workers. J Occup Med Toxicol 2012;7:24.
   

学　歴
2005年05月
2007年05月
2012年03月

マドラス大学（インド）理科学 - バイオテクノロジー  学士
マドラス大学（インド）遺伝学 修士
東洋大学, 生命科学博士  博士

1. External stimulus responsive inorganic nanomaterials for cancer theranostics. M. S. Mohamed, S. Veeranarayanan, T. Maekawa and D. S. Kumar. Advanced Drug Delivery Reviews, 2018, doi.org/10.1016/j.addr.2018.
2. Photodynamic therapy at ultra-low NIR laser power and X-Ray imaging using Cu3BiS3 nanocrystals. S. Veeranarayanan*, M. S. Mohamed*, A. C. Poulose*, M. Rinya, Y. Sakamoto, T. Maekawa and D. S. Kumar. Theranostics, 2018, 8, 5231–5245. (*Authors contributed equally).
3. Self-assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy. M. R. Aji Alex, Chetan Nehate, S. Veeranarayanan, D. Sakthi Kumar, Ritu Kulshreshtha, Veena Koul. Biomaterials, 2017, 133, 94-106.
4. FITC/Suramin Harboring Silica Nanoformulations for Cellular and Embryonic Imaging/Anti-Angiogenic Theranostics. S. Veeranarayanan, Aby CP, Sheikh MM, Yutaka N, Shosaku K, Toru M, D. Sakthi Kumar. J. Mater. Chem., B, 2015, 3, 8079.
5.  Synergistic Targeting of Cancer and Associated Angiogenesis Exercising Triple Targeted-Dual Drug Silica Nanoformulations for Theragnostics. S. Veeranarayanan, Aby CP, Sheikh MM, Saino HV, Yutaka N, Yasuhiko Y, Toru M, Sakthi Kumar D. Small 2012, 8, 3476-3489.
6. GD and transferrin nanoparticle composition. T Maekawa, Sakthi Kumar D, SM Mohamed, S. Veeranarayanan. US Patent 10765637.
7. Drug Delivery Nanoparticle Composition. T Maekawa, Sakthi Kumar D, SM Mohamed, S. Veeranarayanan.  Japan Patent JP6321305B2.

1. Boonsiri T, Watanabe S, Tan XE, Thitiananpakorn K, Narimatsu R, Sasaki T, Takenouchi R, Sato’o Y, Aiba Y, Kiga K, Sasahara T, Taki Y, Li YF, Zhang YC, Azam AH, Kawaguchi T, Cui L. 2020. Identification and characterization of mutations responsible for the β-lactam resistance in oxacillin-susceptible mecA-positive Staphylococcus aureus. Scientific Reports 10(1): 16907.
2. Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato’o Y, Boonsiri T, Li FY, Sasahara T, Taki Y, Azam AH, Zhang YC, Cui L. 2020. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Scientific Reports 10(1): 16107.
3. Kiga K, Tan X-E, Rodrigo IC, Watanabe S, Aiba Y, Sato’o Y, Li F-Y, Sasahara T, Cui B, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Azam AH, Suzuki M, Penadés JR, and Cui L. Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun 11, 2934 (2020). 
4. Aiba Y, Watanabe S, Tsukahara R, Umemoto N, Thitiananpakorn K, Boonsiri T, Li F-Y, Kiga K, Sato’o Y, Tan X-E, Taki Y, Azam AH, Zhang Y, Sasahara T, Demitsu T, Cui L. Complete Genome Sequence of a Panton-Valentine Leukocidin-Negative Staphylococcus aureus Strain Isolated from a Patient with Pervasive Necrotizing Soft Tissue Infection. Microbiology Resource Announcements Jun 2020, 9 (23) e00295-20.
5. Watanabe S, Cui B, Kiga K, Aiba Y, Tan XE, Sato'o Y, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Azam H.A., Nakada Y, Sasahara T, and Cui L., Composition and Diversity of CRISPR-Cas13a systems in the genus Leptotrichia., Frontiers in Microbiology., 10:2838., 2019.
6. Cui B, Watanabe S, Sato'o Y, Nihashi F, Aiba Y, Kiga K, Sasahara T, Tan XE, Kawauchi M, Boonsiri T, Thitiananpakorn K, Taki Y, Li FY, Imokawa S, Cui L. Complete genome sequence of the methicillin-resistant Staphylococcus aureus strain JMUB3031, isolated from a patient with fatal community-acquired pneumonia., Microbiol Resour Announc., 8:e01652-18., 2019.
7. Watanabe S, Aiba Y, Tan XE, Li F.-Y, Boonsiri T, Thitiananpakorn K, Cui B, Sato'o Y, Kiga K, Sasahara T, and Cui L. Complete genome sequencing of three human clinical isolates of Staphylococcus caprae reveals virulence factors similar to those of S. epidermidis and S. capitis. BMC Genomics, 19:810., 2018.
8. Kanprasoet, W, Jensen, LT, Sriprach S, Thitiananpakorn K, Rattanapornsompong K, Jensen AN. Deletion of mitochondrial porin alleviates stress sensitivity in the yeast model of Shwachman-Diamond syndrome. J Genet Genomics, 42:671-684., 2015.
   
9. Jensen, AN, Chindaudomsate W, Thitiananpakorn K, Mongkolsuk S, Jensen LT. Improper protein trafficking contributes to artemisinin sensitivity in cells lacking the KDAC Rpd3p. FEBS Lett. 588(21):4018-25. 2014.
   

学　歴
2012年03月
2014年03月
2021年03月

秋田県立大学　生物資源科学部　卒　学士
群馬大学大学院　工学研究科　卒　修士
群馬大学大学院　理工学専攻　卒　博士

1. Shimamori Y, Mitsunaka S, Yamashita H, Suzuki T, Kitao T, Kubori T, Nagai H, Takeda S, Ando H, Staphylococcal Phage in Combination with Staphylococcus epidermidis as a Potential Treatment for Staphylococcus aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants. Viruses 2021; 13(1): 7.
2. Shimamori Y, Pramono AK, Kitao T, Suzuki T, Aizawa S, Kubori T, Nagai H, Takeda S, Ando H,  Isolation and characterization of a novel phage SaGU1 that infects Staphylococcus aureus clinical isolates from patients with atopic dermatitis. Curr. Microbiol. 2021;10.1007/s00284-021-02395-y.
3. 満仲翔一, 島守祐月, 安藤弘樹, ファージが救う細菌感染症, 現代科学, 2019; 3: 61-65.
4. Tsukamoto N, Kanazawa Y, Shimamori Y, Yoshida K, Takeda S, Identification of a morphogenic intermediate of the bacteriophage Mu Baseplate, Adv. in Microbiol. 2014; 4(3): 1155-1163.
   

Bachelor of Science (B.Sc. Honors), Department of Microbiology, University of Dhaka.
Master of Science (M.S.), Department of Microbiology, University of Dhaka.
PhD in Medical Science, Graduate School of medical and dental science, Niigata University.

Scientific Officer, Institute of food and radiation biology (IFRB), Bangladesh Atomic Energy Commission (BAEC)
Senior Scientific Officer, Institute of food and radiation biology (IFRB), Bangladesh Atomic Energy Commission (BAEC)
Principal Scientific Officer, Institute of food and radiation biology (IFRB), Bangladesh Atomic Energy Commission (BAEC)
Postdoctoral Fellow, Division of Bacteriology, Jichi Medical University, Japan

B.S., Department of Psychology, University of Dhaka.
M.S., Department of Psychology, University of Dhaka.
Ph.D in Molecular neurobiology, Faculty of Medicine, Kagawa University, Japan

B.S.,  Japan

B.S.,  Japan

B.S.,  Japan

学　歴
Jul 2016
Aug 2020
Apr 2021

職　歴
Jul 2016

Bachelor of Medical Science, Southern Medical College, Bangladesh
Research Student, Jichi Medical University
Master's course student, Jichi Medical University

Medical Officer, CSCR Hospital, Bangladesh

学　歴
2020年06月
2021年05月
2022年04月

職　歴

广东医科大学（中国）学士
自治医科大学大学院医学研究科  研究士
自治医科大学大学院医学研究科  大学院生（修士課程）